About: Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	assaig clínic (ca) clinical trial (en) clinical trial (en-ca) clinical trial (en-gb) clinical trial (en-us) ensaio clínico (gl) ensayo clínico (es) ensayu clínicu (ast) essai clinique (fr) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes (en)
skos:prefLabel	Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes (en)
name	Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes (en)
title	wds:Q61907402-E6BD30D6-77B8-47BD-9409-FCB3C91910E7
title	A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of Twelve Once-weekly Subcutaneous Doses of PB-119 to Patients With Type 2 Diabetes Mellitus (T2DM) Not Well-controlled by Metformin Monotherapy (en)
end time	wds:Q61907402-D5B7A216-39CA-42E3-8ABD-EB6505515137
end time	2019-04-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q61907402-41D71F7B-ECC1-4616-BEAF-8F48389A8B2E
instance of	clinical trial
start time	wds:Q61907402-DE9B1C1C-5227-480D-A4A6-2A72BD0A6848
start time	2018-06-13 00:00:00Z (xsd:dateTime)
country	wds:Q61907402-97F656A0-E3BA-4F94-A6BA-1B7906E2D9EE
country	United States of America
research site	wds:Q61907402-12FB271B-299D-4314-979F-9CF5AA6F5AB8
research site	Clinical Pharmacology of Miami
research intervention	wds:Q61907402-7F56C067-C79B-4E2F-B756-007166830629
research intervention	metformin
minimum age	wds:Q61907402-ECDFAA83-0108-49EA-9A57-804902EA2267
minimum age	18 (xsd:decimal)
medical condition	wds:Q61907402-C2E31427-0679-400F-B5B8-603011E1E408
medical condition	diabetes
number of participants	wds:Q61907402-D2D96187-EA84-4B11-A184-BE3B8FEC7DBF
number of participants	240 (xsd:decimal)
maximum age	wds:Q61907402-9090F5C4-BAE2-46DE-89BF-05E3B5CCAECB
maximum age	70 (xsd:decimal)
study type	wds:Q61907402-60B84404-96F1-4D16-AC69-57EA9B378627
study type	interventional study
ClinicalTrials.gov ID	wds:Q61907402-EDC12467-4C39-48B9-A243-2DDB1C7D32FF
ClinicalTrials.gov ID	NCT03604419
clinical trial phase	wds:Q61907402-D49D6713-9F96-4AAD-A445-945EE86BC115
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61907402

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software